SIREN : 510204274
NEOLIANE SANTE is a French company founded 17 years ago, specialized in the sector Activités des agents et courtiers d'assurances. Based in NICE (06200), this company of category ETI shows in 2024 a revenue of 81.4 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-04-25
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 81 357 128 € | 67 557 691 € | 60 288 371 € | 62 357 758 € | 64 811 082 € | 56 627 618 € | 58 744 059 € | 37 674 896 € | 24 621 358 € |
| Net income | 2 189 123 € | 1 263 512 € | 1 203 839 € | 1 977 105 € | 2 365 029 € | 2 369 656 € | 6 945 228 € | 3 184 532 € | 446 844 € |
| EBITDA | 3 919 243 € | 1 785 027 € | 1 328 777 € | 3 066 024 € | 3 541 959 € | 5 229 923 € | 9 788 580 € | 4 978 229 € | 1 313 469 € |
| Net margin | 2.7% | 1.9% | 2.0% | 3.2% | 3.6% | 4.2% | 11.8% | 8.5% | 1.8% |
In 2024, NEOLIANE SANTE achieves revenue of 81.4 M€. Over the period 2016-2024, the company shows strong growth with a CAGR (compound annual growth rate) of +16.1%. Vs 2023, growth of +20% (67.6 M€ -> 81.4 M€). After deducting consumption (0 €), gross margin stands at 81.4 M€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 3.9 M€, representing 4.8% of revenue. Positive scissor effect: EBITDA margin improves by +2.2 pts, sign of improved operational efficiency. The operating margin remains fragile, requiring cost vigilance. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 2.2 M€, i.e. 2.7% of revenue. This profit can be retained or distributed to shareholders.
81 357 128 €
81 357 128 €
3 919 243 €
3 114 061 €
2 189 123 €
4.8%
The debt ratio (= Financial debt / Equity x 100) stands at 1%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 20%. Low autonomy: the company heavily depends on external financing (banks, suppliers). Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 0.0 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability. Cash flow represents 3.5% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment.
1.054%
19.641%
3.509%
0.034
48.2%
In 2024, the debt ratio of NEOLIANE SANTE (1.05) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
In 2024, the financial autonomy of NEOLIANE SANTE (19.6%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
In 2024, the repayment capacity of NEOLIANE SANTE (0.03) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.
The liquidity ratio (= Current assets / Current liabilities) stands at 94.73. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 2.4x. Financial charges are adequately covered by operations.
94.735
2.425
In 2024, the liquidity ratio of NEOLIANE SANTE (94.73) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
In 2024, the interest coverage of NEOLIANE SANTE (2.4x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 40 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 114 days. Excellent situation: suppliers finance 74 days of the operating cycle (retail model). Overall, WCR represents 19 days of revenue, i.e. 4.4 M€ to permanently finance. Over 2016-2024, WCR increased by +35%, requiring additional financing.
4 364 810 €
40 j
114 j
0 j
19 j
Based on 193 transactions of similar company sales (all years), the value of NEOLIANE SANTE is estimated at 27 231 880 € (range 7 716 337€ - 60 728 391€). With an EBITDA of 3 919 243€, the sector multiple of 1.2x is applied. The price/revenue ratio is 0.98x (in line with sector norms). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 193 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare NEOLIANE SANTE with other companies in the same sector:
Voir toutes les statistiques du secteur Activités des agents et courtiers d'assurances
The revenue of NEOLIANE SANTE in 2024 is 81.4 M€.
Yes, NEOLIANE SANTE generated a net profit of 2.2 M€ in 2024.
The headquarters of NEOLIANE SANTE is located in NICE (06200), in the department Alpes-Maritimes.
The tax return of NEOLIANE SANTE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
NEOLIANE SANTE operates in the sector Activités des agents et courtiers d'assurances (NAF code 66.22Z). See the 'Sector positioning' section above to compare the company with its competitors.